Integrating International Value Chains through Biotechnologies

Transcription

1 Conference Integrating International Value Chains through Biotechnologies By Mondher Khanfir Sfax, November 7th,

2 1. The economic shift 2. Globalization of the Value Chains 3. International Value Chains characteristics 4. Where & How investing in IVC 5. Conclusion 2

3 Some preliminary observations Mesurée à partir de données en prix constants, la part des exportations de biens et services dans le PIB mondial a doublé en vingt ans alors qu elle n avait progressé que de 2 points entre 1970 et % des biens et services produits dans le monde sont exportées : l intégration commerciale de l économie mondiale atteint aujourd hui des sommets. Copyright2012@wikistartup 3

4 Some preliminary observations Marchés s'appuyant sur l'offre Production manufacturière Organisation taylorienne Bâtie sur l'optimisation Distribution de proximité S'appuyant sur les mass media Clientèle de masse Rapport de force basé sur le pouvoir Marché s appuyant sur la demande Production de valeur ajoutée Organisation modulaire Bâtie sur l innovation Distribution en réseau S appuyant sur les TIC Customisation rapport de force basé sur l influence Copyright2012@wikistartup 4

5 Some preliminary observations Marchés s'appuyant sur l'offre Production manufacturière Organisation taylorienne Bâtie sur l'optimisation Distribution de proximité S'appuyant sur les mass media Clientèle de masse Rapport de force basé sur le pouvoir Marché s appuyant sur la demande Production de valeur ajoutée Organisation modulaire Bâtie sur l innovation Distribution en réseau S appuyant sur les TIC Customisation rapport de force basé sur l influence Copyright2012@wikistartup 5

6 Exports per capita are cupping 6

7 A steady increase of the GDP per capita (logs) but a decline of the investment share to GDP Source: Comparative study on export policies AFDB 2012 Copyright2012@wikistartup 7

8 with the lowest rate of employement as a share of the working age population Copyright2012@wikistartup 8

9 A shift to a Bioeconomy By 2030, it is estimated that only in Europe, the use of biotechnology will provide - up to 35% of the production of chemical and industrial products, - up to 80% of pharmaceuticals and diagnosis, - and about 50% of agriculture production. Source MEDPRO study 2012 Copyright2012@wikistartup 9

10 Impact on mediterranean developement model Source MEDPRO study

11 IVC characteristics We can consider 3 types of IVC: 1)Primary (based on Agriculture) 2)Secondary (based on industrial activities) 3)Tertiary (Full services) Each IVC is characterized by: 1) Its capability 2) Its worldwide market share & coverage 3) Its competitivness Copyright2012@wikistartup 11

12 A very impressive concentration in the primary IVC 40% à 45% du café torréfié dans le monde est produit par 4 entreprises (alors que le café est produit par 25 millions d agriculteurs) 80% du marché mondial du Thé est contrôlé par 3 multinationales 40% du commerce de cacao mondial est entre les mains de 4 multinationales. La part de la valeur ajoutée revenant aux pays en développement a diminué de ~60% en 1970 à ~28% en Rapport sur le développement dans le monde 2008 Copyright2012@wikistartup 12

13 A huge entry barrier in the secondary IVC J.L.Vouzellaud - Juin

14 How could Tunisia integrate IVC? International competition is at this level Value-chain advantages VCM-based advantages Cluster advantages Innovation advantages Firm-based advantages Organizational advantages Marketing advantages Efficiency advantages Production Capacity advantages The exceptions are those partnerships which transfer know-how to local companies Country-based advantages 14

15 A sharp increase in scientific production but very few is patented. 15

16 a significant investment expected to be fruitful 16

17 Where and how investing in the IVC? Producing & monetizing knowledge Developping Research Based Spin-Off Attracting Biotech operators Bio Labelling Certification Powering the Supply chains with alternative Energy Value Chain RE-CYCLING 17

18 Primary Value Chain analysis Farming Collecting / storing Processing Sales Logistics -Genomic, - Biotechnologies applications (pesticides, fertilisers, ) -Irrigation, Environnement - Bio Packaging - derivatives products -New applications - Branding Bio label -AOC - Green Tech Processes - Bio Energy -Recycling Supply Chains - Information Technologies Copyright2012@wikistartup 18

19 Huge potential of RBSO formation 19

20 Key success factors New strategy for Technologies Transfer More efficient funding of the early stage innovation Better protection of IP Access to international networks Access to global markets Compliance with international standards 20

21 Conclusion BioEconomy shift presents a good opportunity for Tunisia to integrate International Value Chains. There is a real potential for Tunisia to develop a sustainable economic model coherent with the neighbourhood strategy, in particular through Technologies Transfers and Biotech RBSO formation. Copyright2012@wikistartup 21